These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29224201)

  • 1. Changing trends for diagnostic methods in Graves disease in Australia: an immunological diagnosis as the emerging preference.
    Hsieh A; Twigg SM; Chua EL
    Intern Med J; 2017 Dec; 47(12):1464-1465. PubMed ID: 29224201
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' reply.
    Kahaly GJ; Diana T
    J Endocrinol Invest; 2016 Oct; 39(10):1197-8. PubMed ID: 27531171
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity of assays for TSH-receptor antibodies.
    Bitcon V; Donnelly J; Kiaei D
    J Endocrinol Invest; 2016 Oct; 39(10):1195-6. PubMed ID: 27531172
    [No Abstract]   [Full Text] [Related]  

  • 4. [Increased levels of auto-antibodies in thyroid diagnostics: Hashimoto thyroidities or Graves disease?].
    Paschke R
    Internist (Berl); 2006 Nov; 47(11):1193-4. PubMed ID: 17043781
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
    Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
    Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid-stimulating hormone receptor antibody assays: recommendation for correct interpretation of results in Graves disease.
    Massart C; d'Herbomez M
    Clin Chem; 2013 May; 59(5):855. PubMed ID: 23396139
    [No Abstract]   [Full Text] [Related]  

  • 8. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Bucci I; Carpentieri M; Di Nenno B; Di Blasio A; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1080-7. PubMed ID: 22492869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-TSH receptor antibody(TRAb, TBII, TSAb)].
    Amino N; Fujiwara M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():305-8. PubMed ID: 20960786
    [No Abstract]   [Full Text] [Related]  

  • 10. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-TSH receptor antibody (TBII, TSAb)].
    Amino N; Kubota S
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():277-9. PubMed ID: 16149508
    [No Abstract]   [Full Text] [Related]  

  • 12. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TSH receptor antibody measurements--the progress and the point at issue].
    Okamoto Y
    Nihon Rinsho; 2006 Dec; 64(12):2219-26. PubMed ID: 17154082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid controversy--stimulating antibodies.
    Davies TF; Roti E; Braverman LE; DeGroot LJ
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3777-85. PubMed ID: 9814446
    [No Abstract]   [Full Text] [Related]  

  • 16. Graves' disease by any other name?
    Weetman AP
    Thyroid; 2000 Dec; 10(12):1071-2. PubMed ID: 11201851
    [No Abstract]   [Full Text] [Related]  

  • 17. Partial prediction of postpartum Graves' thyrotoxicosis by sensitive bioassay for thyroid-stimulating antibody measured in early pregnancy.
    Ide A; Amino N; Nishihara E; Kudo T; Ito M; Kimura Y; Tatsumi N; Yamazaki M; Miyauchi A
    Endocr J; 2016 Oct; 63(10):929-932. PubMed ID: 27432817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM; Liu W; Lu GH
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current topics on immunological laboratory tests-thyroid diseases].
    Iwatani Y
    Rinsho Byori; 2004 Sep; 52(9):751-8. PubMed ID: 15552935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.